Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 33

Cited In for PubMed (Select 21548464)

1.

TP53 R72P polymorphism modulates DNA methylation in hepatocellular carcinoma.

Rebbani K, Marchio A, Ezzikouri S, Afifi R, Kandil M, Bahri O, Triki H, El Feydi AE, Dejean A, Benjelloun S, Pineau P.

Mol Cancer. 2015 Apr 2;14:74. doi: 10.1186/s12943-015-0340-2.

2.

The role of epigenetics in age-related macular degeneration.

Gemenetzi M, Lotery AJ.

Eye (Lond). 2014 Dec;28(12):1407-17. doi: 10.1038/eye.2014.225. Epub 2014 Sep 19. Review.

PMID:
25233816
3.

Systematic dissection of the mechanisms underlying progesterone receptor downregulation in endometrial cancer.

Yang S, Jia Y, Liu X, Winters C, Wang X, Zhang Y, Devor EJ, Hovey AM, Reyes HD, Xiao X, Xu Y, Dai D, Meng X, Thiel KW, Domann FE, Leslie KK.

Oncotarget. 2014 Oct 30;5(20):9783-97.

4.

The histone deacetylase inhibitor, Vorinostat, represses hypoxia inducible factor 1 alpha expression through translational inhibition.

Hutt DM, Roth DM, Vignaud H, Cullin C, Bouchecareilh M.

PLoS One. 2014 Aug 28;9(8):e106224. doi: 10.1371/journal.pone.0106224. eCollection 2014.

5.

Human factors and pathways essential for mediating epigenetic gene silencing.

Poleshko A, Kossenkov AV, Shalginskikh N, Pecherskaya A, Einarson MB, Marie Skalka A, Katz RA.

Epigenetics. 2014 Sep;9(9):1280-9. doi: 10.4161/epi.32088. Epub 2014 Aug 4.

6.

Methylation status of promoter 1 region of GDNF gene in human glioma cells.

Chen M, Liu Z, Deng Y, Chen X, Zhang J.

Int J Clin Exp Med. 2014 Jul 15;7(7):1735-40. eCollection 2014.

7.

Pathway landscapes and epigenetic regulation in breast cancer and melanoma cell lines.

El Baroudi M, La Sala D, Cinti C, Capobianco E.

Theor Biol Med Model. 2014 May 7;11 Suppl 1:S8. doi: 10.1186/1742-4682-11-S1-S8. Epub 2014 May 7.

8.

Influence of oncogenic transcription factors on chromatin conformation and implications in prostate cancer.

Yang YA, Kim J, Yu J.

Appl Clin Genet. 2014 May 12;7:81-91. doi: 10.2147/TACG.S35598. eCollection 2014. Review.

9.

The role of DNA damage and repair in decitabine-mediated apoptosis in multiple myeloma.

Maes K, De Smedt E, Lemaire M, De Raeve H, Menu E, Van Valckenborgh E, McClue S, Vanderkerken K, De Bruyne E.

Oncotarget. 2014 May 30;5(10):3115-29.

10.

Regulation of microRNAs by epigenetics and their interplay involved in cancer.

Liu X, Chen X, Yu X, Tao Y, Bode AM, Dong Z, Cao Y.

J Exp Clin Cancer Res. 2013 Nov 22;32:96. doi: 10.1186/1756-9966-32-96. Review.

11.

Pharmacokinetics and pharmacodynamics of suberoylanilide hydroxamic acid in cats.

McDonnel SJ, Tell LA, Murphy BG.

J Vet Pharmacol Ther. 2014 Apr;37(2):196-200. doi: 10.1111/jvp.12088. Epub 2013 Nov 18.

12.

Emerging signaling pathways in hepatocellular carcinoma.

Moeini A, Cornellà H, Villanueva A.

Liver Cancer. 2012 Sep;1(2):83-93. doi: 10.1159/000342405. Review.

13.

Synergistic re-activation of epigenetically silenced genes by combinatorial inhibition of DNMTs and LSD1 in cancer cells.

Han H, Yang X, Pandiyan K, Liang G.

PLoS One. 2013 Sep 6;8(9):e75136. doi: 10.1371/journal.pone.0075136. eCollection 2013.

14.

Methylation profiling and evaluation of demethylating therapy in renal cell carcinoma.

Ricketts CJ, Morris MR, Gentle D, Shuib S, Brown M, Clarke N, Wei W, Nathan P, Latif F, Maher ER.

Clin Epigenetics. 2013 Sep 13;5(1):16. doi: 10.1186/1868-7083-5-16.

15.

Role of stromal-epithelial interaction in the formation and development of cancer cells.

Shtilbans V.

Cancer Microenviron. 2013 Dec;6(3):193-202. doi: 10.1007/s12307-013-0131-5. Epub 2013 Feb 22.

16.

Investigation of the expression patterns and correlation of DNA methyltransferases and class I histone deacetylases in ovarian cancer tissues.

Gu Y, Yang P, Shao Q, Liu X, Xia S, Zhang M, Xu H, Shao Q.

Oncol Lett. 2013 Feb;5(2):452-458. Epub 2012 Dec 3.

17.

Efficacy of decitabine-loaded nanogels in overcoming cancer drug resistance is mediated via sustained DNA methyltransferase 1 (DNMT1) depletion.

Vijayaraghavalu S, Labhasetwar V.

Cancer Lett. 2013 Apr 30;331(1):122-9. doi: 10.1016/j.canlet.2012.12.009. Epub 2013 Jan 7.

18.
19.

Epigenetic drugs: a novel anti-aging strategy?

Vaiserman AM, Pasyukova EG.

Front Genet. 2012 Oct 31;3:224. doi: 10.3389/fgene.2012.00224. eCollection 2012. No abstract available.

20.

Silencing of miR-370 in human cholangiocarcinoma by allelic loss and interleukin-6 induced maternal to paternal epigenotype switch.

An F, Yamanaka S, Allen S, Roberts LR, Gores GJ, Pawlik TM, Xie Q, Ishida M, Mezey E, Ferguson-Smith AC, Mori Y, Selaru FM.

PLoS One. 2012;7(10):e45606. doi: 10.1371/journal.pone.0045606. Epub 2012 Oct 22.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk